Kerry MD - ProKidney Corp VP Affairs
| PROK Stock | USD 3.96 0.25 6.74% |
Insider
Kerry MD is VP Affairs of ProKidney Corp
| Address | 2000 Frontis Plaza Blvd., Winston-Salem, NC, United States, 27103 |
| Phone | 336 999 7028 |
| Web | https://www.prokidney.com |
ProKidney Corp Management Efficiency
The company has return on total asset (ROA) of (0.2134) % which means that it has lost $0.2134 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3172) %, meaning that it created substantial loss on money invested by shareholders. ProKidney Corp's management efficiency ratios could be used to measure how well ProKidney Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is expected to rise to 0.03 this year, although the value of Return On Tangible Assets will most likely fall to (0.09). Total Current Liabilities is expected to rise to about 26.3 M this year, although the value of Liabilities And Stockholders Equity will most likely fall to about 223.3 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jasna Penich | Malaga Financial | 65 | |
| John Tellenbach | Malaga Financial | 56 | |
| Jerry Donahue | Malaga Financial | 85 | |
| Li He | MicroAlgo | 37 | |
| David Moore | Americold Realty Trust | 57 | |
| Robert Bass | Americold Realty Trust | 50 | |
| Khara Julien | Americold Realty Trust | 41 | |
| Randy Bowers | Malaga Financial | 73 | |
| David Iwasaka | Malaga Financial | N/A | |
| Thomas CPA | Americold Realty Trust | 64 | |
| Chengwei Yi | MicroAlgo | 48 | |
| Mark Bustamante | Malaga Financial | N/A | |
| Shiwen Liu | MicroAlgo | 42 | |
| Pamela Kohn | Americold Realty Trust | 56 | |
| Robert Chambers | Americold Realty Trust | 40 | |
| James Smigiel | SEI Investments | 55 | |
| Sacha Ohara | Malaga Financial | 52 | |
| Leslie Wojcik | SEI Investments | N/A | |
| Donald Lee | Malaga Financial | N/A | |
| Joe McCabe | SEI Investments | N/A | |
Management Performance
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.21 |
ProKidney Corp Leadership Team
Elected by the shareholders, the ProKidney Corp's board of directors comprises two types of representatives: ProKidney Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ProKidney. The board's role is to monitor ProKidney Corp's management team and ensure that shareholders' interests are well served. ProKidney Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ProKidney Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph MD, VP Devel | ||
| Ashley Johns, VP Operations | ||
| James CPA, Chief Officer | ||
| Richard Williams, Senior Technology | ||
| Aparna MD, VP Development | ||
| Kerry MD, VP Affairs | ||
| Bruce MD, CEO Director | ||
| Mary Weger, Chief Officer | ||
| Esq JD, Chief Sec | ||
| Darin Weber, VP Devel | ||
| Deepak Jain, Chief Officer | ||
| Dr DVM, Founder Advisor | ||
| Nikhil PereiraKamath, Chief Officer | ||
| Pharm MPH, Senior Relations | ||
| Libbie MD, Chief Officer | ||
| MPH MD, Senior Procedures |
ProKidney Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ProKidney Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.21 | ||||
| Current Valuation | 1.35 B | ||||
| Shares Outstanding | 63.92 M | ||||
| Shares Owned By Insiders | 6.70 % | ||||
| Shares Owned By Institutions | 51.96 % | ||||
| Number Of Shares Shorted | 9.89 M | ||||
| Price To Book | 91.32 X | ||||
| EBITDA | (148.35 M) | ||||
| Net Income | (35.47 M) |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as ProKidney Corp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProKidney Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for ProKidney Stock analysis
When running ProKidney Corp's price analysis, check to measure ProKidney Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProKidney Corp is operating at the current time. Most of ProKidney Corp's value examination focuses on studying past and present price action to predict the probability of ProKidney Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProKidney Corp's price. Additionally, you may evaluate how the addition of ProKidney Corp to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is ProKidney Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.57) | Return On Assets (0.21) | Return On Equity (0.32) |
The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.